Beam Therapeutics Inc. (BEAM) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 (Transcript)

Question-and-Answer SessionGreat. So I was wondering if you could start off by providing an overview of the company and any upcoming catalysts that investors should keep in mind?John EvansCEO & Director Sure. So Beam Therapeutics is a next-generation gene editing company. We use an important form of CRISPR called base editing, in which we use the same precision targeting ability of CRISPR to edit any spot in the genome, but we've modified the system so that it doesn't make double-stranded breaks where you l ...